Albert Seymour - 01 Jan 2023 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Signature
/s/ W. Bradford Smith, Attorney-in-Fact for Albert Seymour
Issuer symbol
QTTB
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 15:35:00 UTC
Previous filing
08 Sep 2022
Next filing
20 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIXX Common Stock Options Exercise +4,290 +3.2% 139,856 01 Jan 2023 Direct F1, F2
transaction FIXX Common Stock Options Exercise +6,930 +5% 146,786 01 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Restricted Stock Units Options Exercise $0 -4,290 -49% $0.000000 4,420 01 Jan 2023 Common Stock 4,290 Direct F1, F3
transaction FIXX Restricted Stock Units Options Exercise $0 -6,930 -33% $0.000000 14,070 01 Jan 2023 Common Stock 6,930 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2 Includes 3,920 shares acquired under Issuer's Employee Stock Purchase Plan on August 31, 2022.
F3 The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.
F4 The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.

Remarks:

President and Chief Executive Officer